$115.0 Million
Revance Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$200.0 Million
CRISPR Therapeutics AG
Follow-On Offering
Active Bookrunner
$197.8 Million
Deciphera Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$111.3 Million
OptiNose AS
Follow-On Offering
Active Bookrunner
$260.3 Million
Xencor, Inc.
Follow-On Offering
Active Bookrunner
$57.5 Million
Novavax, Inc.
Follow-On Offering
Active Bookrunner
$57.5 Million
Eloxx Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$71.8 Million
Rigel Pharmaceuticals, Inc.
Follow-On Offering
Active Bookrunner
$202.4 Million
Aimmune Therapeutics, Inc.
Follow-On Offering
Active Bookrunner
$265.5 Million
argenx SE
Follow-On Offering
Active Bookrunner
Subscribe to Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.